Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Common Stock | Options Exercise | $249K | +4.5K | +121.21% | $55.42 | 8.21K | Mar 14, 2025 | Direct | |
transaction | CNMD | Common Stock | Tax liability | -$254K | -4.32K | -52.55% | $58.83 | 3.9K | Mar 14, 2025 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | SARs (Stock Appreciation Rights) | Options Exercise | $0 | -4.5K | -100% | $0.00 | 0 | Mar 14, 2025 | Common Stock | 4.5K | $55.42 | Direct | F1 |
Id | Content |
---|---|
F1 | The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |